Compare AMBA & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMBA | OGN |
|---|---|---|
| Founded | 2004 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.6B |
| IPO Year | 2011 | 2020 |
| Metric | AMBA | OGN |
|---|---|---|
| Price | $67.00 | $13.76 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 5 |
| Target Price | ★ $89.36 | $11.25 |
| AVG Volume (30 Days) | 1.2M | ★ 2.0M |
| Earning Date | 11-24-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 0.58% |
| EPS Growth | ★ 37.32 | N/A |
| EPS | N/A | ★ 0.95 |
| Revenue | $295,402,000.00 | ★ $6,216,000,000.00 |
| Revenue This Year | $12.88 | N/A |
| Revenue Next Year | $13.35 | $2.51 |
| P/E Ratio | ★ N/A | $14.48 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $48.30 | $5.69 |
| 52 Week High | $96.69 | $13.83 |
| Indicator | AMBA | OGN |
|---|---|---|
| Relative Strength Index (RSI) | 51.73 | 54.03 |
| Support Level | $59.89 | $13.46 |
| Resistance Level | $71.06 | $13.77 |
| Average True Range (ATR) | 3.54 | 0.04 |
| MACD | 0.21 | -0.00 |
| Stochastic Oscillator | 75.98 | 34.78 |
Ambarella Inc is a developer of low-power system-on-a-chip, or SoC, semiconductors and software for edge and physical artificial intelligence (AI) applications and intelligent automation. Its products are used in a wide variety of human viewing, computer vision for edge and physical AI applications, including a variety of video security cameras, automotive camera systems, fixed robots, autonomous mobile robots (AMRs), industrial applications, intelligent transportation systems, and consumer devices, such as action, drone and 360 degree cameras. The company operates as a single operating and reportable segment and derives substantially all of its revenue from development and sales of low-power AI-based processing and video and image processing SoC solutions.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.